Loading...
Retrospective longitudinal study of patients and prescriber characteristics associated with new DOAC prescriptions in a CCG without restrictions to DOAC use
Fay, M. Petty, Duncan R.
Fay, M.
Petty, Duncan R.
Publication Date
2018
End of Embargo
Supervisor
Rights
© 2018 Wiley.
This is the peer reviewed version of the conference abstract above, which has been published in final form at https://doi.org/10.1111/ijpp.12442. This article may be used for non-commercial purposes in accordance with Wiley Terms and Conditions for Self-Archiving.
Peer-Reviewed
Yes
Open Access status
openAccess
Accepted for publication
Institution
Department
Awarded
Embargo end date
Collections
Additional title
Abstract
Direct oral anticoagulants (DOACs) uptake for stroke prevention in atrial fibrillation has been slow.[1] This study aimed to profile the prescribing of DOACs over three years to identify factors associated with DOAC prescribing in a Clinical Commissioning Group (CCG) without restrictions to DOACs use. The objectives were to identify:
- Characteristics of patients prescribed oral anticoagulant (OAC) in a sample of general practices;
- Who initiated the prescribing of OAC;
- Recorded reasons for prescribing a DOAC rather than warfarin;
Version
Accepted manuscript
Citation
Medlinskiene K, Fay M and Petty D (2018) Retrospective longitudinal study of patients and prescriber characteristics associated with new DOAC prescriptions in a CCG without restrictions to DOAC use. International Journal of Pharmacy Practice. 26 (Suppl.1): 26-27.
Link to publisher’s version
Link to published version
Link to Version of Record
Type
Abstract